(ASX:RAD) Radiopharm Receives Strategic Investment for up to A$18 million
• Lantheus has agreed to make an initial strategic equity investment of A$7.5 million in Radiopharm • Offer price for the shares of A$0.05 represents a 47% premium to the…
Aldoro Resources (ASX:ARN) LATEST KAMEELBURG ASSAYS UP TO 10.38% Nb2O5 AND 9.89% TREO
Highlights • A total of 74 highly prospective rock samples recently collected from various beforsite and mafic dykes • Most notable assays reveal up to 10.38% Nb2O5 and 9.89% TREO…
ASX:DRO – DroneShield Awarded $4.7 Million Contract
• A $4.7 million contract for multiple vehicle-based C-UxS systems from a new customer. • Further material orders are anticipated from this customer. DroneShield Ltd (ASX:DRO) (DroneShield or the Company)…
ASX admits first Bitcoin ETF
“As the demand for digital assets continues to grow, we are proud to offer a regulated avenue forAustralian investors to access the crypto asset market,” Mr Campion said ASX today…
CLB AND SCALARE SIGN SHARE SALE AND MERGER IMPLEMENTATION DEEDS
CLB AND SCALARE SIGN SHARE SALE AND MERGER IMPLEMENTATION DEEDS • CLB and Scalare have signed a Merger Implementation Deed and a Share Sale Agreement to facilitate the acquisition of…
ASX:IRE, Unauthorised access to Iress code repository
Iress advises that on Saturday 11 May 2024 it detected and contained an unauthorised accessing of Iress’user space on GitHub, a third-party code repository platform which manages software code before…
PFT, Pure Foods – Capital Raise
The Company is inviting Eligible Shareholders the opportunity to participate in a non-renounceable pro-rata 1 for 2 Entitlement Offer (Rights Issue) at an issue price of $0.04 per Share, to…
ASX, APX, Appen, Withdrawal of Innodata’s non-binding indicative proposal for Appen
On 12 March 2024, Appen received a price and volume query letter from the ASX which it responded to on that day. As part of Appen’s response to the price…
ASX, MSB, MESOBLAST SUCCESSFULLY COMPLETES PLACEMENT AND ACCELERATED ENTITLEMENT OFFER
Melbourne, Australia; March 14 and New York, USA; March 13, 2024: Mesoblast Limited (ASX:MSB; Nasdaq:MESO), global leader in allogeneic cellular medicines for inflammatory diseases, today announced it has received firm…
ASX, PO3, CHANGE OF COMPANY SECRETARY, Simon Lill
CHANGE OF COMPANY SECRETARY PuriflOH Limited (PuriflOH, PO3 or Company) advises that in accordance with ASX Listing Rule 3.16.1, due to his other commitments, Simon Lill has decided to resign…